News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Alnylam Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Beach
The Day In Review: Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Pays $515 Million For AnorMED
September 26, 2006
·
1 min read
Biotech Beach
The Day In Review: Threshold Pharmaceuticals, Inc. Crushed On Trial Failure
July 17, 2006
·
1 min read
Biotech Beach
The Day In Review: MGI PHARMA, INC. Sells Ex-US Dacogen Rights
July 6, 2006
·
1 min read
Biotech Beach
The Day In Review: Merck & Co., Inc. Gobbles Up Two Biotechs
May 9, 2006
·
1 min read
Biotech Beach
The Day In Review: Biotechs Update Hepatitis C News
May 1, 2006
·
1 min read
Biotech Beach
The Day In Review: Biotech IPOs Get Chilly Reception
April 12, 2006
·
1 min read
Genetown
Scientists “Silence Gene” To Slash Cholesterol Levels
March 30, 2006
·
1 min read
The Day In Review: Biotech Takes A Beating
October 19, 2005
·
1 min read
Genetic Technique Used To Cut Cholesterol
October 19, 2005
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Alnylam to Host Tenth “RNAi Roundtable” Webcast Series
June 12, 2026
·
4 min read
Press Releases
GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region
June 10, 2026
·
3 min read
Press Releases
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
June 4, 2026
·
7 min read
Press Releases
Alnylam Issues 2025 Corporate Responsibility Report
May 19, 2026
·
4 min read
Press Releases
New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden
May 12, 2026
·
10 min read
Press Releases
Alnylam to Webcast Presentations at Upcoming Investor Conferences - May 7, 2026
May 7, 2026
·
1 min read
Press Releases
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM
May 4, 2026
·
9 min read
Press Releases
Alnylam Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Period Progress
April 30, 2026
·
19 min read
Press Releases
Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026
April 27, 2026
·
9 min read
Press Releases
Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial Results
April 17, 2026
·
1 min read
